Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
Ross Baker, Professor at The University of Notre Dame Australia, Founding Chair of Perth Blood Institute, Professor and Director at Western Australian Centre for Thrombosis and Haemostasis (WACTH) Murdoch University, Director of Hollywood Hospital Haemophilia Treatment Centre, shared a post on LinkedIn:
“Heavy menstrual bleeding and inherited bleeding disorders are leading causes of iron deficiency—often missed and undertreated.
The new ASH 2026 guidelines recommend screening all women with HMB or inherited bleeding disorders for iron deficiency using a higher ferritin threshold of 50 ng/mL or less—especially before anaemia develops. Early diagnosis and treatment can improve quality of life and health outcomes.
The Perth Blood Institute is launching a women’s blood health initiative in November to boost awareness and best practices for iron deficiency in people affected by heavy menstrual bleeding and bleeding disorders.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI